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Virulence of Pseudomonas aeruginosa is typically
attributed to its type III secretion system (T3SS). A
taxonomic outlier, theP. aeruginosaPA7 strain, lacks
a T3SS locus, and no virulence phenotype
is attributed to PA7. We characterized a PA7-related,
T3SS-negative P. aeruginosa strain, CLJ1, isolated
from a patient with fatal hemorrhagic pneumonia.
CLJ1 is highly virulent in mice, leading to lung hemor-
rhage and septicemia. CLJ1-infected primary endo-
thelial cells display characteristics of membrane
damage and permeabilization. Proteomic analysis
of CLJ1 culture supernatants identified a hemo-
lysin/hemagglutinin family pore-forming toxin, Exoly-
sin (ExlA), that is exported via ExlB, representing
a putative two-partner secretion system. A recom-
binant P. aeruginosa PAO1DpscD::exlBA strain, defi-
cient for T3SS but engineered to express ExlA,
gained lytic capacity on endothelial cells and full viru-
lence in mice, demonstrating that ExlA is necessary
and sufficient for pathogenicity. This highlights
clinically relevant T3SS-independent hypervirulence,
isolates, and points to a broader P. aeruginosa path-
ogenic repertoire.
INTRODUCTION
Pseudomonas aeruginosa is a Gram-negative bacterium that in-
habits most available environments and is a major opportunistic
human pathogen. It causes acute or chronic infections, espe-
cially in patients with underlying debilitating conditions, including
patients with cystic fibrosis, cancer, AIDS, or extensive burns.
In intensive care units (ICUs), P. aeruginosa causes approxi-164 Cell Host & Microbe 15, 164–176, February 12, 2014 ª2014 Elsemately 40% of ventilator-associated pneumonia-related deaths
(Crouch Brewer et al., 1996). Because of the raising number of
P. aeruginosa strains resistant to almost all available antibiotics,
these infections have become a real health problem in hospital
settings (Peterson, 2009; Talbot et al., 2006). The availability of
several P. aeruginosa whole-genome sequences (http://www.
pseudomonas.com/; Winsor et al., 2011), including those of
the laboratory strain PAO1 and the clinical isolates PA14 and
LESB54, has allowed correlation of the genome content and
the relative pathogenicity assayed in different animal models
(Battle et al., 2008; Lee et al., 2006; Stover et al., 2000; Winstan-
ley et al., 2009). The size of the P. aeruginosa genome ranges
between 5.5 and 7.0 Mbp, with a conserved core genome
and numerous genomic islands (GIs), which are DNA insertions
containing a variable number of so-called ‘‘accessory’’ genes
(Klockgether et al., 2011; Kung et al., 2010). These GIs are in-
serted into regions of genome plasticity (RGPs) and contribute
to an extreme mosaic genome structure (Mathee et al., 2008).
The GIs may contain important virulence determinants and reg-
ulatory genes, as exemplified by the 11 kb-island PAPI-2 encod-
ing the potent cytotoxin ExoU, that is exported and injected into
eukaryotic cells by a type III secretion system (T3SS) machinery
(He et al., 2004; Kulasekara et al., 2006). However, most GIs
carry genes of unknown functions. The capacity of the bacterium
to cause different kinds of infectious diseases is attributed
to its metabolic diversity and an array of secreted and sur-
face-associated molecules recognized as virulence factors.
The T3SS-secreted toxins, flagellum, LPS, and quorum-sensing
(QS)-regulated exported enzymes have been all clearly impli-
cated in virulence (reviewed in Kipnis et al., 2006). Moreover, a
recent multiparametric study performed on clinical isolates
demonstrated a direct link between mortality in acute mouse
models and both T2SS-exported elastase and T3SS toxins (Le
Berre et al., 2011). The acute toxicity of P. aeruginosa toward
eukaryotic cells strongly correlates with the expression of
T3SS and the repertoire of T3S toxins (Berthelot et al., 2003;
Engel and Balachandran, 2009; Shaver andHauser, 2004; Vancevier Inc.
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zymes. ExoT- and ExoY-encoding genes are present in all iso-
lates, while exoS and exoU are mutually exclusive (Berthelot
et al., 2003; Faure et al., 2003; Feltman et al., 2001). ExoT,
ExoS, and ExoY are enzymes possessing activities that mimic
eukaryotic proteins involved in signal transduction (Barbieri
and Sun, 2004; Hauser, 2009; Yahr et al., 1998). Their injection
into the host cell cytoplasm dramatically changes the cell
behavior at the level of adhesion, motility, and phagocytosis
and in turn affects cell viability. ExoU is the most potent
cytotoxin, present in approximately 30% of strains associated
with the most severe infections, including septicemia (Berthelot
et al., 2003; Finck-Barbanc¸on et al., 1997). This toxin harbors a
phospholipase activity and is capable of inducing rapid lysis of
eukaryotic cell membranes, provoking necrosis (Gendrin et al.,
2012; Sato et al., 2003). Out of 13 available genomes refer-
enced on the Pseudomonas Genome web site (http://www.
pseudomonas.com/), the PA7 strain, classified as a taxonomic
outlier, is the only one that does not harbor the 20 kb T3SS locus
and lacks all T3S toxin genes (Roy et al., 2010). This strain,
collected in Argentina from a patient with nonrespiratory infec-
tion, exhibits a multidrug resistance phenotype and possesses
several novel GIs and putative virulence determinants (Roy
et al., 2010). However, to date no virulence phenotype has
been reported for the PA7 strain.
In this work, we report the phenotypic and genomic character-
ization of a particular P. aeruginosa strain isolated from a patient
suffering from hemorrhagic pulmonary infection and treated in
the ICU of Grenoble University Hospital (Grenoble, France). We
discovered that this strain, although lacking the whole T3SS
locus and all exotoxin genes, exhibited a highly cytotoxic pheno-
type through an original virulence strategy, using a cytotoxin ex-
ported via a two-partner secretion (TPS) system. Similar clinical
strains have been identified in differentP. aeruginosa collections,
thus underlining the necessity to survey P. aeruginosa diversity
and to gain a global view of its pathogenic repertoire.
RESULTS
A Case of Fatal Necrotizing Hemorrhagic Pneumonia
due to P. aeruginosa
During a systematic phenotypic analysis of P. aeruginosa clinical
isolates, we paid special attention to a series of strains isolated
from the same patient admitted to the ICU of Grenoble Univer-
sity Hospital. The patient suffered from chronic obstructive
pulmonary disease. He presented with febrile chest pain,
hemoptysis, and respiratory distress. A chest X-ray showed a
diffuse alveolar infiltrate and a pleural effusion of the left lung,
and the patient was intubated and mechanically ventilated.
Hemorrhagic respiratory samples obtained by bronchoalveolar
lavage (BAL) or tracheal suctioning led to the isolation of 106
cfu/ml of P. aeruginosa. The obtained P. aeruginosa isolate,
named CLJ1, was susceptible to almost all antibiotics tested,
including antipseudomonal b-lactams, aminoglycosides, and
fluoroquinolones. Piperacillin 4 g three times a day and tobramy-
cin 4 mg/kg/day were started. Because of subsequent septic
shock, fever, and new left lower lobe opacities, a BAL was per-
formed on day 5 posthospitalization and recovered 106 cfu/ml
P. aeruginosa. The isolate (not stored) was susceptible toCell Host &penems, aminoglycosides, ciprofloxacine, colimycin, and fosfo-
mycin but resistant to other antibiotics. The antibiotherapy was
switched to meropenem and amikacin with doses adapted
to the impaired renal function. On day 12, the respiratory
status again worsened, and tracheal aspirates grew 107 cfu/ml
P. aeruginosa. Two colonies that differed in size (CLJ2 and
CLJ3) were stored, and their antibiotic susceptibility was deter-
mined. Three P. aeruginosa samples were evaluated for their
cytotoxicity and their susceptibility to antibiotics. We observed
a decrease in virulence but an increase in antibiotic resistances
(see Table S1 available online) between the early CLJ1 strain
and later CLJ2 and CLJ3 strains, although the three strains share
the same rep-PCR profile. The patient was treated accordingly
but did not recover from multiple organ dysfunctions and died
1 month posthospitalization.
The CLJ1 Strain Is Cytotoxic to Macrophages
Independently of T3SS
To get insights into the virulence mechanisms of CLJ strains, we
first performed cytotoxicity assays on J774macrophages, moni-
tored by LDH release. This test is commonly used to measure le-
thal effects of P. aeruginosa strains that are dependent on T3SS
activity levels and the nature of the exported toxins; ExoU-pro-
ducing strains are more efficient in cytolysis than the ExoS-ex-
pressing strains (Berthelot et al., 2003; Dacheux et al., 2000).
As reported previously, cell lysis provoked by PAO1 was depen-
dent upon a functional T3SS, as a deletion in pscD, encoding an
essential inner membrane machinery component, abolished
cytotoxic activity (Figure 1A). Interestingly, only CLJ1 showed a
high lytic activity toward macrophages, while CLJ2 and CLJ3
were either weakly cytotoxic or noncytotoxic (Figure 1A). To
evaluate the potential T3SS activity of CLJ1, we cultured the
bacteria in the presence of the Ca2+ chelator EGTA, known to
induce the expression of T3SS proteins (Yahr et al., 1997), and
examined total bacterial lysates for the presence of PcrV and
ExoU. Immunoblotting analysis (Figure 1B) confirmed the pres-
ence of PcrV in two control strains, PAO1 and PP34 (Berthelot
et al., 2003), while ExoU was detected only in the bacteremia
PP34 isolate, as expected. Surprisingly, none of the three CLJ
strains synthesized PcrV or ExoU. Moreover, and contrary to
what we could observe with a majority of P. aeruginosa clinical
strains, overexpression of the T3SS transcriptional activator
ExsA (Dacheux et al., 2001; Thibault et al., 2009) in CLJ strains
did not restore the synthesis of PcrV and ExoU (data not shown).
This was reminiscent of the PA7 strain known to lack the whole
T3SS locus (Roy et al., 2010). However, as opposed to CLJ1,
PA7 showed minimal level of cytotoxicity to macrophages
(Figure 1A).
CLJ Isolates Are PA7-like P. aeruginosa Strains
To examine the CLJ genomes, we set up PCR assays (Table S2)
that allowed discrimination between PAO1- and PA7-like
P. aeruginosa strains (Figure 1C). The lasR gene present in all
strains was used as a positive control. The primers designed to
amplify one end of the T3SS locus and part of the bordering
gene gave a 866 bp PCR product only with PAO1 gDNA, while
a set of primers designed to anneal at external sides of the
deletion boundaries gave a 847 bp PCR product with PA7
gDNA, as well as with all three CLJ DNAs (see the SupplementalMicrobe 15, 164–176, February 12, 2014 ª2014 Elsevier Inc. 165
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Figure 1. P. aeruginosa CLJ1 Strain Is Hyper-
virulent in a T3SS-Independent Manner
(A) Cytotoxicity of different strains measured by LDH
release from infected J774 macrophages. Infection
was performed at multiplicity of infection (moi) of 10
and quantity of cell lyses determined from each
isolate 3 hr postinfection (p.i.). The data are ex-
pressed as the mean percentage (±SD) of LDH
release.
(B) Western blot analysis of whole-cell lysates of
strains grown in T3S-inducing conditions. Antibodies
used were against T3S machinery component PcrV
and themost potent T3S exported toxin, ExoU. RpoA
was used as a loading control.
(C)Ampliconsobtained togenetically characterizeCLJ
strains. Primers are described in Table S2. The lasR
gene is amplified fromgenomicDNAof all strains. PCR
reactionusingprimersdesigned toamplify a part of the
T3SS locus was positive only in PAO1 strain, while it
was absent from PA7 and all CLJ strains. toxA is
present only in PAO1. PA7-specific sequences were
readily amplified using gDNA from CLJ strains (oprA,
PSPA7_1407, PSPA7_4642, PSPA7_2109). The
20_$85 sequence is specific to CLJ.
(D) Bacterial suspensions (5 3 106) were instilled in
mouse airways to provoke acute pneumonia. Ka-
plan-Meyer survival curves for mice infected with
PAO1, PAO1DpscD, CLJ1, PA7, or PP34 (n = 10 in
each group). Statistical differences: multiple com-
parison by log rank test p < 0.001; single compari-
sons with CLJ1, as established by log rank test, are
indicated on the diagram.
(E) Bacterial dissemination was investigated by CFU determination in blood and spleen at 16 hr p.i. (n = 5 per group). Each value is represented by a circle;
the median is represented by a red bar. Statistical analysis: Kruskal-Wallis multiple comparison test: p < 0.01 for the two data sets (blood and spleen);
single comparisons with CLJ1 data were performed by permutation test, and results are shown above data.
Related to Tables S1 and S2.
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PA7 revealed the absence of the toxA gene but the presence
of several strain-specific genes and GIs (Roy et al., 2010). We
selected few of them for analysis (oprA, PSPA7_1407,
PSPA7_4642, and PSPA7_2109) to corroborate the similarity
between PA7 and CLJ1-3. Indeed, the four amplicons were ob-
tained from gDNAs of CLJ strains, while they were not amplified
from PAO1 gDNA. toxA was absent from all CLJ strains, as
expected. Therefore, we conclude here that the three isolates
CLJ1, CLJ2, and CLJ3 are related to the sequenced PA7 strain
by their genome composition. Furthermore, the preliminary draft
genome sequence of the CLJ1 strain revealed that it possesses,
in addition, several specific GIs present neither in PA7 nor in
PAO1 (20_$85 amplicon in Figure 1C).
CLJ1 Infection Leads to Lethal Lung Hemorrhage in a
Mouse Model of Acute Pneumonia
As previously reported, P. aeruginosa T3SS is a major determi-
nant of bacterial cytotoxicity and dissemination inmousemodels
of acute pneumonia (Kang et al., 1997; Sawa et al., 1999; Shaver
and Hauser, 2004). To examine CLJ1 virulence in vivo, we
instilled CLJ1, PAO1, PAO1DpscD, PA7, or PP34 strains in
mouse airways and established survival curves (Figure 1D). All
mice infected with CLJ1 died within 48 hr. Although not signifi-
cant (p = 0.12), CLJ1 has a tendency to be even more toxic
than PAO1 in this assay but is less toxic than PP34 (p < 0.001).166 Cell Host & Microbe 15, 164–176, February 12, 2014 ª2014 ElseConversely, PA7 and PAO1DpscD exhibited no or little toxicity,
in agreement with the known importance of the T3SS in in vivo
infection. CLJ1 toxicity in this model was thus unpredicted. To
better characterize the infection process, we investigated bacte-
rial dissemination in blood and spleen after lung infection (Fig-
ure 1E). In both organs, the number of disseminated bacteria
at 16 hr p.i. was similar for PAO1 and CLJ1 infections, while
PA7 strain poorly disseminated. CLJ1 is thus capable to cross
epithelial and vascular barriers similarly to PAO1 and to provoke
systemic infections from a pulmonary entry site.
We then studied the histological modifications of infected
lungs. In PAO1-, PA7-, and CLJ1-infected mice, lungs were
highly congestive, and alveolar walls were thickened in most
areas, as illustrated in Figure 2A. Importantly, some bronchioli
from PAO1- or PA7-infected lungs were filled with neutrophils
(arrows in Figure 2A), indicating a massive extravasation of
immune cells. Accumulation of neutrophils in infected lungs
was confirmed by Gr1 antibody labeling of lung sections (data
not shown). In CLJ1-infected lungs, neutrophil infiltration also
occurred, but alveoli were clearly hemorrhagic, and some bron-
chioli contained red blood cell accumulations (arrowheads in Fig-
ure 2A). Red blood cell effusion in alveoli and presence of the red
cells in bronchioli were scored in five infected mice for each bac-
terial strain. Data showed a striking difference betweenCLJ1 and
the two other strains (Figure S1), thereby suggesting that CLJ1
may be specifically deleterious to the alveolovascular wall.vier Inc.
AB
Figure 2. Histology of Infected Lungs and Analysis of Bronchoalveolar Lavages
Bacterial suspensions (5 3 106) were instilled in mouse airways to provoke acute pneumonia, and mice were euthanized at 16 hr p.i.
(A) Hematoxylin and eosin staining of lung sections showing alveolar areas (upper panels) or bronchioli (lower panels) frommock-infected lungs (PBS), or infected
with PAO1, PA7, or CLJ1 strains, as indicated. In uninfected lungs, alveolar spaces were empty (*), while these spaces were strikingly reduced in infected lungs,
because of vessel congestion, alveolar wall thickening, and blood cell infiltration. Some bronchioli were filled with neutrophils (arrows) in PAO1- and PA7-infected
lungs, while part of them contained red blood cells after CLJ1 infection (arrowhead). In control, bronchioli from uninfected lungs were empty (#). Effusion of red
blood cells was also observed in alveolar spaces (arrowheads).
(legend continued on next page)
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performed BAL and analyzed their hemoglobin, myeloperoxi-
dase, and protein contents, reflecting red cell and neutrophil
contents, and edema, respectively. BAL fluids from CLJ1-in-
fected lungs contained the highest amounts of hemoglobin, as
suspected from the histological analysis (Figure 2B), and also
the highest amounts of proteins, although differences were
only significant between CLJ1 and PAO1 BAL fluids (p < 0.05).
Interestingly, PA7 BAL fluids possessed the strongest myelo-
peroxidase activities, while CLJ1 BAL fluids had the lowest. Alto-
gether, these in vivo data show that CLJ1-infected lungs are
hemorrhagic, whereas PAO1 or PA7 infection triggers a massive
neutrophilic infiltration but little hemorrhage.
Human Primary Endothelial Cells Infected by CLJ1 Die
from Membrane Damage
To examine the molecular mechanisms of CLJ1 pathogenicity,
we set up a series of cellular tests. Most of P. aeruginosa strains
are known to trigger endothelial cell retraction within 4–4.5 hr via
T3SS effectors (Huber et al., 2013). ExoS or ExoT injection
induces Rho GTPase inactivation and cofilin activation, leading
to actin filament severing and depolymerization (Huber et al.,
2013). We thus tested whether similar impact on cell morphology
can be elicited by the CLJ1 bacteria. Measurement of the relative
cell area after infection of confluent HUVEC monolayers with
PAO1 or CLJ1 revealed that CLJ1-infected cells exhibited sub-
stantially faster and more extensive retraction in comparison to
cells infected with PAO1 (Figure 3A).
To visualize this dramatic outcome of infection on primary
endothelial cells, we performed labeling of filamentous actin
(F-actin) and VE-cadherin, a marker of cell-cell junctions (Fig-
ure 3B). At 3 hr p.i., CLJ1-infected HUVECs were all retracted
with total disruption of cell-cell junctions and disorganization of
F-actin. At comparable time points, monolayers of PAO1-in-
fected cells exhibited only partial loss of VE-cadherin labeling
(arrowheads), and overall cell morphology assessed by organi-
zation of actin stress fibers still remained relatively intact. To
visualize the kinetics of F-actin remodeling during infection, we
performed time-lapse video microscopy of live HUVECs ex-
pressing Lifeact, an RFP-coupled peptide with high affinity to
F-actin. In PAO1-infected cells, the actin cytoskeleton gradually
collapsed over a period of approximately 4 hr, thereby provoking
cell retraction (Movie S1; selected frames in Figure 3C). In CLJ1-
infected cells, the linear actin fibers rapidly disappeared in favor
of faint actin filaments with ‘‘zigzag’’ shape, just prior to complete
cell retraction (Movie S2; selected frames in Figure 3C).
Altogether, these results show that both cell-cell junctions and
actin cytoskeleton are more rapidly disorganized in CLJ1- than
in PAO1-infected cells. Because of the modification in actin
stress fiber organization during infection by CLJ1, rather than
just disruption, it is likely that actin fibers are affected by different
mechanism(s) from that described for PAO1 infection (i.e., cofilin
activation; Huber et al., 2013).(B) BAL fluids were collected and centrifuged as described in the Experimental Pro
on the pellets, and supernatant protein concentration was determined. Each ci
medians are represented by a red bar. Statistics: Kruskal-Wallismultiple comparis
were performed by permutation tests and results are shown above data.
Related to Figure S1.
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capable to provoke LDH release from epithelial and endothelial
cells at 3 hr p.i. (Berthelot et al., 2003; Finck-Barbanc¸on et al.,
1997). We submitted epithelial (HeLa and A549) and endothelial
(BAEC and HUVEC) cells to CLJ1 and measured the LDH
release. Strikingly, all four cell lines were highly susceptible to
CLJ1 infection (data not shown). We further characterized
CLJ1 cytotoxicity on HUVECs and performed cytotoxic assay
over a period of 3 hr (Figure 4A). While the ExoU-positive strain
PP34 induced the highest level of HUVEC lysis in the first 2 hr
of infection, the CLJ1 strain reached the same levels at 3 hr
p.i., suggesting that CLJ1 has a similar potential to induce
membrane disintegration, yet independently of ExoU. To further
investigate a membrane permeabilization activity of CLJ1, we
performed infection experiments in the presence of ethidium
bromide (EtBr), a membrane-impermeable DNA-intercalator,
and followed its accumulation in HUVEC nuclei by time-lapse
fluorescence videomicroscopy. When compared with ExoU-
mediated membrane permeabilization induced by PP34 strain,
which occurs stochastically over a 1 hr period, the CLJ1 effects
on membrane integrity are simultaneous, progressive, and
delayed in time (Movie S3 and Movie S4). Therefore, although
both strains rapidly induced membrane permeability leading
to necrotic cell death, the molecular mechanisms seem to be
different. In comparison, PAO1 and PA7 strains induced partial
retraction but not permeabilization to EtBr in the 141 min time
period (Movie S5 and Movie S6; Figure 4B), and the mock-in-
fected cells were neither retracted nor permeabilized (Movie
S7; Figure 4B).
CLJ1 Aggressiveness Correlates with the Synthesis of
Exolysin, a Two-Partner Secreted Cytolysin
The eukaryotic membrane damages induced by bacterial patho-
gens are frequently due to pore-forming toxins. In order to
explore the pore-forming potential of CLJ1, the culture superna-
tants of PA7 and CLJ1 were compared by LC-MS/MS. Among
proteins identified exclusively in the CLJ1 sample by at least
ten peptides, three candidates were predicted to be extracellular
(Table 1). These included the aminopeptidase PepB, the chiti-
nase ChiC, and an uncharacterized protein annotated in the
databases as a hemolysin belonging to a family of proteins clas-
sified as hemagglutinins/hemolysins secreted through a special-
ized TPSpathway inGram-negative bacteria (Leo et al., 2012). All
hemolysin peptides identified by mass spectrometry showed
100% identity to the predicted PSPA7_4642 gene product.
Further examination of the P. aeruginosa genomes (http://www.
pseudomonas.com/; Winsor et al., 2011) demonstrated that the
PSPA7_4642 gene was present exclusively in the PA7 genome
while absent from PAO1 and other sequenced P. aeruginosa
strains (Figure 5A). The PSPA7_4642 protein is highly homolo-
gous (35% identity) to Serratia marcescens hemolysin ShlA and
was named Exolysin. BLAST searches identified other Exolysin
homologs, all belonging to the same family of hemolysins.cedures. Hemoglobin amounts andmyeloperoxidase activities weremeasured
rcle represents the data calculated for total BAL fluids (n = 5 in each group);
on test, p < 0.004 for the three data sets; for single comparisons with CLJ1, data
vier Inc.
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ChlA from pathogenic Chromobacterium violaceum (Brumbach
et al., 2007) and between 28% and 33% identity with Proteus
mirabilis HpmA (Weaver et al., 2013), Edwardsiella tarda EthA
(Strauss et al., 1997), and Photorhabdus luminescens PhlA (Bril-
lard et al., 2002), all reported to possess cytolytic activities.
Indeed, the analysis of the ExlA protein sequence revealed a
high degree of homology between these proteins within the
so-called TPS domain, encompassing 300 amino acids of the N
terminus (Figure 5B). Indeed, in PA7 and CLJ chromosomes,
the Exolysin-encoding gene, exlA, is adjacent and downstream
to a gene encoding an outer-membrane protein (PSPA7_4641,
exlB; Figure 5A) homologous to ShlB that is required for export
and activity of ShlA (Yang and Braun, 2000). Thus, ExlB and
ExlA representmembers of the growing family of TpsBAproteins.
The differential detection, by mass spectrometry, of ExlA
polypeptides in supernatants of CLJ1 compared to PA7 promp-
ted us to test the levels of the toxin synthesis in different strains
(Figure 5C). As positive control, the exlBA sequence was
cloned under arabinose-inducible promoter and introduced in
P. aeruginosa PAO1. Antibodies raised against three synthetic
ExlA-derived peptides detected a protein of expected size
(172 kDa), exclusively in the extracts of the ExlA-expressing
PAO1 strain (PAO1+exlBA; Figure 5C, left panel). Furthermore,
Exolysin was readily found in culture supernatants of both
PAO1+exlBA and CLJ1, whereas no protein could be revealed
in PA7 or CLJ3 samples. The CLJ2 supernatant contained
intermediate quantities of the toxin. Altogether, these Exolysin
expression data correlate with levels of strain cytotoxicity on
macrophages and HUVECs, further implicating Exolysin in
CLJ1 virulence.
Because the CLJ1 strain was found refractory to gene
knockout, to investigate the role of ExlA we have chosen the
strategy of heterologous expression coupled with phenotypic
analysis. The P. aeruginosa PAO1 and PAO1DpscD strains
both secreting ExlA were used to infect HUVECs, and cytotox-
icity was assessed by measuring the LDH release and the incor-
poration of EtBr in cell nuclei (Figures 5D and 5E). Notably, the
expression of exlBA was sufficient to gain the cytolytic pheno-
type upon native PAO1 and PAO1DpscD strains. As expected,
neither exlB nor exlA alone had obvious phenotype on HUVECs.
Furthermore, ExlBA expression in E. coli, although dramatically
affecting the bacterial growth, was sufficient to cause cell lysis
(Figures 5D and 5E). Thus, the synthesis of this TPS hemo-
lysin-like protein, Exolysin, and its partner ExlB correlates with
P. aeruginosa cytotoxicity on endothelial cells.Figure 3. CLJ1 Induces Cell Retraction, Actin Cytoskeleton Disorganiz
(A) Confluent HUVECs were infected with PAO1 or CLJ1 strains (moi = 10). Nonin
cells were fluorescently labeled with actin antibody to uniformly stain the entir
magnification, and the percentage of the image surface covered by cells was calcu
tested with one-way ANOVA: p < 0.001 at 2 and 5 hr. Single comparisons to CL
(B) Analogous experiment in which cells were fixed at 2 hr p.i. and colabeled for VE
nuclei in blue. At this time point, PAO1-infected cells showed areas of absent (*)
structures were totally disrupted in CLJ1-treated cells.
(C) HUVECswere transfected with Lifeact-RFP and infected 24 hr later with PAO1
from Movie S1 and Movie S2. Postinfection times are indicated. Arrowheads sho
CLJ1-treated cells, while this phenomenon is much slower with PAO1. In CLJ1-in
(arrows).
Related to Movie S1 and Movie S2.
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P. aeruginosa virulence in the mouse model of acute infection,
P. aeruginosa strains lacking T3SS (PAO1DpscD) but harboring
either the empty vector (DpscD+ctrl) or the vector expressing
exlBA (DpscD+exlBA) were used to infect mice as described
previously. Clearly, ExlBA expression was sufficient to induce
toxicity comparable to that of CLJ1, and significantly different
from that ofDpscD+ctrl strain (Figure 5F). As for CLJ1, the hemo-
globin and protein contents of the BAL fluids were significantly
higher in lungs infected with PAO1+exlBA than with PAO1+ctrl
(Figure 5G), indicating that the exlBA locus is responsible for
the hemorrhage and the edema observed during CLJ1 infection.
Finally we searched for similar strains in diverse P. aeruginosa
cohorts by testing exoS/exoU-negative strains for presence of
exlBA sequences. As summarized in Table 2, six strains of
different origins were found to cluster, genotypically and pheno-
typically, in the same PA7/CLJ lineage; e.g., they lack the T3SS
locus but possess exlBA genes and the potential to secrete
Exolysin. Altogether, our data demonstrate that ExlA is the major
weapon responsible for CLJ1 hypertoxic phenotype and that the
similar strains are widely spread in different hospital settings in
European and American continents.
DISCUSSION
P. aeruginosa-associated infections in hospital settings, notably
in ICUs, frequently result in patient death due to the absence of
effective antibiotic therapy. In addition to acquisition of pananti-
biotic resistance, P. aeruginosa strains are armed with a diversity
of virulence factors, some encoded in GIs. In this work we iso-
lated a clinically relevant strain of P. aeruginosa belonging to
the PA7-type clonal outliers that has acquired a hypervirulent
phenotype. We demonstrated that its toxicity is independent of
the major infectious determinant of the bacterium, namely the
T3SS and its effectors (Hauser, 2009; Hauser, 2011). We found
that the CLJ1 strain is extremely efficient in lysing eukaryotic
cells, and this observation correlated with its highly toxic pheno-
type in a mouse pneumonia model. Indeed, CLJ1 was able to
provoke mouse death as efficiently as the T3SS-proficient
PAO1 strain. However, the analysis of lung lesions showed that
the mechanism of killing was apparently different. Histological
data and BAL fluid analysis both showed that CLJ1-infected
lungs were subjected to hemorrhagic lesions. In contrast,
PAO1 and PA7 triggered massive inflammation but little
red cell extravasation. CLJ1-induced lung hemorrhage is in
line with the clinical picture of the patient with necrotizingation, and Cell-Cell Junction Disruption
fected (NI) cells were used as control. Infection was stopped at 2 and 5 hr, and
e cell body. Three fields for each condition were randomly captured at low
lated. Data are themean (+ SD) of total cell surface. Multiple comparisons were
J1 were established by Student’s t test, *p < 0.001.
-cadherin (green) and filamentous (F)-actin (red). The merge images also show
or faint (arrowheads) VE-cadherin labeling but intact actin cytoskeleton. Both
or CLJ1 strains (moi = 10). Videomicroscopy images of RFP labeling were taken
w actin fibers at the beginning of infection. Actin fibers rapidly disorganized in
fected cells, not with PAO1, a faint actin network remained, with zigzag shape
vier Inc.
AB
Figure 4. CLJ1 Induces Plasma Membrane Permeability
(A) Cell death of HUVECswas determined 3 hr p.i. with different strains as indicated. The release of LDHwasmeasured as in Figure 1A. The data are expressed as
the mean percentage (±SD) of LDH release. The level of CLJ1-induced cell death is comparable to the one observed with ExoU-positive strain PP34.
(B)ConfluentHUVECswere infectedwithPAO1,PA7,PP34, orCLJ1.Noninfected (NI) cellswereusedasnegativecontrol,whilePP34, known to inject themembrane
permeabilizing exotoxin ExoU, was used as positive control. Infection was done in the presence of 10 mg/mL EtBr to monitor membrane permeabilization. Images
were taken fromMovieS3,MovieS4,MovieS5,MovieS6, andMovieS7at timepoint 141minp.i. andshowmergedphasecontrast and redchannel (EtBr) images.At
thispoint,cells treatedwitheitherCLJ1orPP34exhibitedEtBrstaining,butstainingwasprogressiveandsynchronized inCLJ1-infectedcells (MovieS4),whilePP34-
infected cells became suddenly and stochastically permeable to the dye (Movie S3). In contrast, PAO1- or PA7-infected cells did not exhibit EtBr accumulation.
Related to Movie S3, Movie S4, Movie S5, Movie S6, and Movie S7.
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Pseudomonas aeruginosa Virulence and Exolysinhemorrhagic pneumonia from whom the strain was derived.
Altogether, these features suggest that CLJ1 exerts a specific
and dramatic action on the alveolovascular barrier, provokingCell Host &its rupture. This may have devastating effects in the lung
but also permits bacteria dissemination in the body, as assessed
by CFU counts in blood and spleen. Interestingly, P. aeruginosaMicrobe 15, 164–176, February 12, 2014 ª2014 Elsevier Inc. 171
Table 1. List of Proteins Specifically Identified in CLJ1 Secretome
Locus Tag Gene Name Product Name Predicted Localization Pep/SC PA01 Homolog
PSPA7_2223a pepB Probable aminopeptidase Extracellulara 21/40 Yes
PSPA7_2949a chiC Chitinase Extracellulara 24/38 Yes
PSPA7_3281a fahA Fumarylacetoacetase Cytoplasmica 11/13 Yes
PSPA7_4642a exlAb Probable hemolysin Extracellulara 11/11 No
PSPA7_4616a astB N-succinylarginine dihydrolase Cytoplasmica 11/11 Yes
PSPA7_1354a purL Phosphoribosylformylglycin-amidine Cytoplasmica 10/10 Yes
Culture supernatants of CLJ1 and PA7 were analyzed using shotgun proteomics. Proteins identified with at least ten spectral counts (SC) only in CLJ1
are listed. Proteins predicted to be exported are indicated as extracellular. Pep/SC, number of identified peptides and spectral counts. The whole list of
identified proteins is provided in Table S3. Related to Table S3.
aFrom http://www.pseudomonas.com/.
bGene name given in this work.
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Pseudomonas aeruginosa Virulence and Exolysinhas been previously associated with lethal hemorrhagic pulmo-
nary damages in farmed minks (Neovison vison), but the mecha-
nism of this type of virulence has never been examined at the
molecular level (Salomonsen et al., 2013). However, other bacte-
ria, such as Staphylococcus aureus expressing the powerful
toxin Panton-Valentine leukocidin (Labandeira-Rey et al., 2007)
and Streptococcus pneumoniae expressing the cholesterol-
dependent cytolysin pneumolysin, are frequently found associ-
ated with lethal pulmonary hemorrhage (Rubins and Janoff,
1998).
Our results strongly suggest that CLJ1 major toxicity is linked
to its capacity to induce plasma membrane permeabilization
leading to necrotic cell death. The genome and proteomemining
highlighted the presence of a P. aeruginosa cytolysin, named
here Exolysin, encoded within a two-gene genetic element
present exclusively, in addition to CLJ1, in the sequenced
genome of the PA7 outlier (Roy et al., 2010). The corresponding
gene PSPA7_4642 and the neighboring gene PSPA7_4641 are
predicted to form an operon and could be considered as part
of an accessory P. aeruginosa genome. However, they were
not previously listed as GI or RGPs, since the element carries
less than four genes. Exolysin is a 172 kDa protein belonging
to the family of Gram-negative bacteria’s hemolysins/hemagglu-
tinins, which are exported by a specialized TPS pathway, also
named T5SS (Henderson et al., 2004; Jacob-Dubuisson
et al., 2013). The PSPA7_4641 gene (exlB) encodes a 60 kDa
outer-membrane protein belonging to the Omp85 superfamily
of transporters. These proteins, known as TpsB, are shown
to be required for secretion of two model proteins, the
S. marcescens hemolysin ShlA (Hertle, 2002) and the major
adhesin of Bordetella pertussis, the filamentous hemagglutinin
(FHA) (Delattre et al., 2011).
The expression of exlBA in trans in PAO1 was found sufficient
to provide the cytolytic phenotype on noncytolytic strains,
showing that the toxin is able to be exported by a heterologous
P. aeruginosa strain in its active form, and that the two-gene
operon harbors all necessary information for its function. More-
over, the secretion of Exolysin alone conferred full pathogenicity
upon a nonvirulent, T3SS-negative strain in an acute mouse
model of infection. The Exolysin sequence presents several
N-proximal motifs conserved in the FHA/ShlA family, including
the TPS secretion motifs ILNEV and NPNGI (Hodak et al.,
2006) (Figure 5B). Structural data obtained from truncated ver-172 Cell Host & Microbe 15, 164–176, February 12, 2014 ª2014 Elsesions of FHA (Kajava et al., 2001) and P. mirabilis HpmA (Weaver
et al., 2013) showed that these proteins fold in elongated all b
sheet molecules which require activation during the export
and, in some cases, undergo proteolytical processing. While
much knowledge has been acquired onmechanisms concerning
the TPS-dependent export, almost nothing is known on how this
type of hemolysins perforates the cell membranes and provokes
the animal death. Intriguingly, Exolysin harbors five Arg-Gly-
Asp (RGD) tripeptide motifs also present in one copy in the
B. pertussis FHA (Relman et al., 1990). These motifs are usually
involved in eukaryotic cell attachment and integrin recognition
(Ruoslahti, 1996), but their roles in cell intoxication by Exolysin
are currently unknown.
The three CLJ strains originally isolated from the same patient
all harbor exlA; however, only the first isolate exhibited strong
cytolytic activity, related to high levels of Exolysin detected in
bacterial secretomes, showing that Exolysin is differentially syn-
thesized betweenCLJ strains. Future comparison betweenCLJ1
and CLJ3 strains on the whole-genome, transcriptome, and pro-
teome levels should reveal mechanisms of virulence regulation.
Furthermore, CLJ2 and CLJ3 clones acquired high-level resis-
tances to the majority of the tested antibiotics, suggesting an
opposite regulation between resistance and virulence.
Distribution of PA7/CLJ1-like strains in hospital settings may
be largely underestimated, as most clinical strains are analyzed
in terms of T3SS effectors or by classical clonal analysis, which
may not be sufficiently precise to identify them. Some reports
suggest that PA7-like strains may be associated with different
kind of acute and chronic infections, including in patients with
cystic fibrosis (Roy et al., 2010). Furthermore, we were able to
detect the exlA gene in several strains coming from diverse
P. aeruginosa cohorts, showing the existence of CLJ1/PA7-like
strains in hospital settings in Europe and the United States.
Those strains, similar to CLJ series, demonstrate variable Exoly-
sin synthesis and ExlA-related cytotoxicity (summarized in Table
2). Moreover, eight additional members of the PA7 lineage have
been sequenced (De´raspe et al., 2013), and all harbor the exlA
gene. Multiresistance phenotype of these T3SS-negative and
exlBA-positive P. aeruginosa, which may be from now on asso-
ciated with highly virulent mechanisms of infection, should
prompt us to systematically scan clinical strain collections for
Exolysin expression. Because of tremendous animal toxicity of
strains synthetizing Exolysin and the toxin role in destruction ofvier Inc.
A C
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Figure 5. Exolysin ExlA Is Required and Sufficient to Provoke Membrane Permeabilization and Fatal Hemorrhage in Mice Infected by
P. aeruginosa Lacking T3SS
(A) Organization of the exlBA locus. The comparison between PAO1 and PA7 was done using the data available at http://www.pseudomonas.com/.
(legend continued on next page)
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Table 2. Origin and Genotypic and Phenotypic Characterization of PA7-like Strains
Strain PA7 CLJ1 DSM1128 Zw26 70 213 JT87 BL043
Origin Burn
(Argentina)
COPD ICU
(Grenoble,
France)
(2010)
Outer ear
infection
(ATCC9027,
deposited in
1980) (USA)
CF airways,
Karlsruhe
Clinic
(Germany)
(1996)
Non-CF
bronchiectasis,
Freeman Hospital
Newcastle-upon-
Tyne (UK) (2008)
Non-CF
bronchiectasis,
Freeman Hospital
Newcastle-upon-
Tyne (UK) (2011)
Urinary tract
infection, University
Hospitals (Cleveland,
USA)
Bacteremia
(Chicago,
USA)
Genotype T3SS locus/exlA+
ExlA secretion /+ +++ ++ +   + ++
EtBr cytotoxicity + +++ ++ +   ++ +++
P. aeruginosa strains were selected upon absence of exoS/exoU. The genotypic analysis was performed by PCR as indicated in Figure 1C. ExlA secre-
tion and EtBr-cytotoxicity onHUVEC cells were evaluated as described in Figures 5C and 5E, respectively. The strains were provided by J. Klockgether
(B. Tu¨mmler’s lab, Hannover, Germany) for DSM1128 and Zw26, C. Winstanley (Liverpool, UK) for 70 and 213 (De Soyza et al., 2013), A. Rietsch
(Case Western Reserve University, Cleveland, USA) for JT87, and A. Hauser (Northwestern University, Chicago, USA) for BL043.
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an antimicrobial target for treatment of specific P. aeruginosa
infections.
EXPERIMENTAL PROCEDURES
Ethical Statement
All protocols in this study were conducted in strict accordance with the French
guidelines for the care and use of laboratory animals. The protocols for mouse
infection were approved by the animal research committee of the institute
(CETEA, numbers 12-021 and 12-022). P. aeruginosa-induced lung injury is
described in the Supplemental Information.
Strain Isolation and Characterization
The clonality of strains was determined using the rep-PCR technology
(Diversilab, bioMe´rieux) (Doleans-Jordheim et al., 2009; Ratkai et al., 2010).
Identification of P. aeruginosa strains was obtained both by phenotypic
methods (Vitek II, bioMe´rieux, Marcy l’Etoile, France) and by amplification
and sequencing of the 16S rRNA encoding gene (Zbinden et al., 2007). Antibi-
otic susceptibility testing was performed using Kirby-Bauer disk diffusion
method, and MICs were interpreted using standards established by Clinical
and Laboratory Standards Institute (CLSI) for P. aeruginosa. For further genetic
and phenotypic characterization, P. aeruginosa strains were grown in liquid LB
medium or on pseudomonas isolation agar (Difco) plates. PAO1 strain (PAO1F)
and its isogenic mutant PAO1DpscD, used in this study, were from the A.
Rietsch laboratory (Case Western Reserve University).
T3SS Phenotypes and Cytotoxicity
Capacity of strains to express T3S proteins PcrV and ExoU was evaluated by
immunobloting using total polyclonal sera raised in rabbits against recombi-(B) ClustalW2 alignment of N-terminal TPS domains of hemolysins ShlA, EthA,
B. pertussis hemagglutinin FHAwas included. Identical amino acids are colored in
The first RGD motif (out of five) of ExlA is in red letters. The conserved CxxC mo
(C) Immunoblotting using specific anti-Exolysin antibodies. Bacterial cell extrac
were run on SDS-PAGE, transferred on the membrane, and revealed by anti-Exoly
control (RpoA) is shown below. The CLJ strains even in exponential phase of grow
either pSW196 alone (PAO1+ctrl) or pSW196+exlBA (PAO1+exlBA) were cultiv
indicated by an arrow. (*) indicates an ExlA-derived degradation product observe
(D) HUVECs were infected with different strains harboring pSW196-exlBA, pSW1
Cytotoxicity was measured by the LDH release, and the data are expressed as the
correlates with presence of exlBA.
(E) HUVECs were infected as in (D), and the EtBr incorporation was evaluated
EtBr-positive nuclei.
(F) Kaplan-Meyer survival curves for mice infected with CLJ1, PAO1DpscD+ctrl
comparison by log rank test, p = 0.0005; single comparisons with CLJ1, as esta
(G) Analysis of BAL fluids (hemoglobin, myeloperoxidase, and protein contents) fro
calculated for total BAL fluids (n = 5 in each group); medians are represented by
three data sets; for single comparisons with CLJ1, data were performed by perm
174 Cell Host & Microbe 15, 164–176, February 12, 2014 ª2014 Elsenant PcrV (Goure et al., 2005) and ExoU (Gendrin et al., 2012). Anti-RpoA
was a monoclonal antibody from NeoClone. Cytotoxic phenotype was evalu-
ated as described previously (Dacheux et al., 2000).
Molecular Biology Manipulations
Amplifications and cloning are done by standard procedures. Details on primer
sequences and exlBA constructions are given in the Supplemental Experi-
mental Procedures.
Anti-Exolysin Antibodies
For ExlA detection, extracellular proteins were concentrated by a TCA-sarko-
syl method (Chevallet et al., 2007). Antibodies against Exolysin were raised in
rabbits by Biotem (http://www.biotem.fr). Rabbits were immunized by three
synthetic peptides derived from the predicted protein sequence of the
PSPA7_4642 gene. The anti-ExlA serum was used at 1:500 dilutions. Anti-
RpoA (Neoclone) was used as loading control. The secondary anti-rabbit-
HRP antibody (Sigma) was used at 1:20,000 dilution.
Cell Culture and Transfection
Human umbilical vein endothelial cells (HUVECs) were isolated according
to previously described protocols (Huber et al., 2013). HUVECs were grown
in endothelial-basal-medium (EBM-2, Lonza). HUVECs were transfected
with 5 mg of Lifeact-RFP plasmid using nucleofection (Amaxa Biosystems)
according to manufacturer’s instructions. Immunofluorescence staining,
cell retraction, and permeability assays are described in the Supplemental
Information.
Proteomic Analysis
LC/MS-MS analysis was performed directly on fresh bacterial supernatants
grown in LB. Details are given in the Supplemental Information.PhlA, and ChlA with P. aeruginosa ExlA (PSPA7_4642). The TPS domain of
dark blue. Conservedmotifs involved in TPS secretion are highlighted in green.
tif absent in ExlA is shown by red box.
ts (concentrated 203) and bacterial culture supernatants (concentrated 403)
sin antibodies. Note the absence of ExlA in total bacterial extracts. The loading
th undergo some cell lysis. The strains used are as indicated. PAO1 harboring
ated in the presence of 0.05% of arabinose. The ExlA protein of 172 kDa is
d specifically in PAO1+exlBA samples.
96-exlB or pSW196-exlA. E. coli pSW196-magD was used as negative control.
mean percentage (±SD) of LDH release. Note the gain of cytolytic activity that
by microscopy. The data are expressed as the mean percentage (±SD) of
or PAO1DpscD+exlBA (n = 11 in each group). Statistical differences: multiple
blished by log rank test, are indicated on the diagram.
m infectedmice was performed as in Figure 3B. Each circle represents the data
a red bar. Statistics: Kruskal-Wallis multiple comparison test, p < 0.004 for the
utation tests, and results are shown above data.
vier Inc.
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